AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
|
01 July 2009 |
Favourable Vote from FDA Advisory Committee on Seroquel Paediatric Applications
|
12 June 2009 |
AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix
|
05 June 2009 |
AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration
|
02 June 2009 |
AstraZeneca Regulatory Update on Seroquel XR for the Treatment of Major Depressive Disorder
|
30 May 2009 |
AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA
|
12 May 2009 |
FDA Advisory Committee Recommendation on Seroquel XR Supplemental New Drug Applications
|
15 April 2009 |
AstraZeneca and MAP Pharmaceuticals, Inc. Announce Worldwide Collaboration
|
02 March 2009 |
AstraZeneca PLC Fourth Quarter and Full Year Results 2008
|
30 January 2009 |
AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration
|
20 December 2008 |